Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-14.93	68.96	81.07
Graham Fair Price	147.35	7771.40	3141.89
PEG	-99.79	< 0.005	1.93
Price/Book	2.40	0.50	0.49
Price/Cash Flow	60.10	-0.74	-1.86
Prices/Earnings	-81.22	2.74	-14.57
Price/Sales	-16.14	4.21	5.02
Price/FCF	60.10	-0.74	-1.86
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-2.03	0.91	0.92
Operating Margin	-0.04	0.58	0.58
ROA	416.43	< 0.005	< 0.005
ROE	< 0.005	0.05	445.37
ROIC	< 0.005	< 0.005	3.97
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.07	0.15	-51.90
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	5.87	0.29	-95.02
EPS QOQ	0.08	6.78	8870.19
FCF QOQ	-1.90	-1.72	9.51
Revenue QOQ	-0.02	0.29	1639.15
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.00	0.00	0.00
Days Sales Outstanding (DSO)	384.91	959.63	149.31
Inventory Turnover	0.00	0.00	0.00
Debt/Capitalization	0.82	0.82	0.26
Quick Ratio	0.36	0.52	44.61
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	7213.45	7640.25	5.92
Cash	6143.71	3913.59	-36.30
Capex	-11.89	-15.66	-31.68
Free Cash Flow	-1906.97	-5184.48	-171.87
Revenue	705.61	912.57	29.33
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	0.03	0.00	inf
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	73.03	62.08	-15.00
Naive Interpretation	Member

06 - Financial Health · Bad

Rating